Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8
Marija Trajkovic, Theo J. Visser, Jens Mittag, Sigrun Horn, Jan Lukas, Veerle M. Darras, Genadij Raivich, Karl Bauer, Heike Heuer
Marija Trajkovic, Theo J. Visser, Jens Mittag, Sigrun Horn, Jan Lukas, Veerle M. Darras, Genadij Raivich, Karl Bauer, Heike Heuer
View: Text | PDF
Research Article Endocrinology

Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8

  • Text
  • PDF
Abstract

In humans, inactivating mutations in the gene of the thyroid hormone transporter monocarboxylate transporter 8 (MCT8; SLC16A2) lead to severe forms of psychomotor retardation combined with imbalanced thyroid hormone serum levels. The MCT8-null mice described here, however, developed without overt deficits but also exhibited distorted 3,5,3′-triiodothyronine (T3) and thyroxine (T4) serum levels, resulting in increased hepatic activity of type 1 deiodinase (D1). In the mutants’ brains, entry of T4 was not affected, but uptake of T3 was diminished. Moreover, the T4 and T3 content in the brain of MCT8-null mice was decreased, the activity of D2 was increased, and D3 activity was decreased, indicating the hypothyroid state of this tissue. In the CNS, analysis of T3 target genes revealed that in the mutants, the neuronal T3 uptake was impaired in an area-specific manner, with strongly elevated thyrotropin-releasing hormone transcript levels in the hypothalamic paraventricular nucleus and slightly decreased RC3 mRNA expression in striatal neurons; however, cerebellar Purkinje cells appeared unaffected, since they did not exhibit dendritic outgrowth defects and responded normally to T3 treatment in vitro. In conclusion, the circulating thyroid hormone levels of MCT8-null mice closely resemble those of humans with MCT8 mutations, yet in the mice, CNS development is only partially affected.

Authors

Marija Trajkovic, Theo J. Visser, Jens Mittag, Sigrun Horn, Jan Lukas, Veerle M. Darras, Genadij Raivich, Karl Bauer, Heike Heuer

×

Figure 7

Expression of the T3-regulated genes RC3 and TRH in the striatum and in the PVN.

Options: View larger image (or click on image) Download as PowerPoint
Expression of the T3-regulated genes RC3 and TRH in the striatum and in ...
(A) Compared with that in wild-type controls, RC3 mRNA expression in the striatum was modestly decreased in MCT8-null mice and strongly in athyroid Pax8–/– mice. After treatment with T4 (200 ng/g BW for 3 consecutive days), striatal RC3 mRNA levels increased in MCT8 mutants and in Pax8–/– mice as well as in control animals. Scale bar: 1.5 mm. (B) The evaluation was validated by NIH image analysis of the hybridization signals. *P < 0.05; **P < 0.0001. (C) In hypothalamic PVN neurons, ISH analysis revealed highly upregulated TRH mRNA levels in MCT8-null mice and athyroid Pax8–/– mice compared with control animals. After treatment with T4 (200 ng/g BW for 3 consecutive days), TRH mRNA expression was strongly reduced in wild-type animals as well as in MCT8 mutants and Pax8–/– mice. Scale bar: 450 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts